Next, mouse tumor xenograft models, including colon cancer (CT26), melanoma (B16-F10), breast cancer (4T1), and non-small cell lung cancer (LLC), were established to investigate the anti-tumor effects of BCAA in vivo. Here, ARID4B is linked to malignant colon neoplasm.